-transparent.png){kind=logo}
Kallikrein was orally administered to 44 patients with male infertility at a dose of 90 or 120 KU/day for three months. The sperm density, sperm motility and fertility index (F.I.) were improved in 51.1%, 37.2% and 38.9% of the treated patients, respectively. Statistical analysis showed that significant improvement was noted in sperm density and F.I. between before and after the treatment, but not in sperm motility, sperm volume nor sperm morphology. During the period of treatment, in these treated 44 patients, 4 patients (9.1%) succeeded in pregnancy.
Related Publications
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
January 1979,
Advances in experimental medicine and biology,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
December 1975,
Zeitschrift fur Hautkrankheiten,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
January 1990,
International urology and nephrology,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
January 1994,
Nihon Sanka Fujinka Gakkai zasshi,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
August 2009,
Minerva ginecologica,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
June 1985,
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
April 2020,
Cells,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
January 1985,
Annales de biologie clinique,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
March 1992,
The Journal of the Association of Physicians of India,
N Takasaki, and
T Ogita, and
H Tonami, and
A Shimizu, and
N Ueno, and
H Okano
December 2004,
Investigacion clinica,
